WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (44)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiyama, K.
Right arrow Articles by Okamoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiyama, K.
Right arrow Articles by Okamoto, T.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 1999, 19(15):6538-6548

Caveolin-3 Upregulation Activates beta -Secretase-Mediated Cleavage of the Amyloid Precursor Protein in Alzheimer's Disease

Kazutoshi Nishiyama1, Bruce D. Trapp1, Tsuneya Ikezu1, Richard M. Ransohoff1, Taisuke Tomita2, Takeshi Iwatsubo2, Ichiro Kanazawa3, Karen K. Hsiao4, Michael P. Lisanti5, and Takashi Okamoto1

1 Department of Neurosciences, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, 2 Faculty of Pharmaceutical Sciences, Tokyo University, Tokyo, Japan, 3 Division of Neuroscience, Graduate School of Medicine, Tokyo University, Tokyo, Japan, 4 Department of Neurology, University of Minnesota, Minneapolis, Minnesota, and 5 Department of Molecular Pharmacology and The Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York

Here, we investigate the involvement of caveolins in the pathophysiology of Alzheimer's disease (AD). We show dramatic upregulation of caveolin-3 immunoreactivity in astroglial cells surrounding senile plaques in brain tissue sections from authentic AD patients and an established transgenic mouse model of AD. In addition, we find that caveolin-3 physically interacts and biochemically colocalizes with amyloid precursor protein (APP) both in vivo and in vitro. Interestingly, recombinant overexpression of caveolin-3 in cultured cells stimulated beta -secretase-mediated processing of APP. Immunoreactivities of APP and presenilins were concomitantly increased in caveolin-3-positive astrocytes. Because the presenilins also form a physical complex with caveolin-3, caveolin-3 may provide a common platform for APP and the presenilins to associate in astrocytes. In AD, augmented expression of caveolin-3 and presenilins in reactive astrocytes may alter APP processing, leading to the overproduction of its toxic amyloid metabolites.

Key words: Alzheimer's disease; caveolin; presenilin; amyloid precursor protein; secretase; astrocyte


Copyright © 1999 Society for Neuroscience  0270-6474/99/19156538-11$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. I. Boulware, H. Kordasiewicz, and P. G. Mermelstein
Caveolin Proteins Are Essential for Distinct Effects of Membrane Estrogen Receptors in Neurons
J. Neurosci., September 12, 2007; 27(37): 9941 - 9950.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Wood, J. S. Nye, N. J. C. Lamb, A. Fernandez, and M. Kitzmann
Intracellular Retention of Caveolin 1 in Presenilin-deficient Cells
J. Biol. Chem., February 25, 2005; 280(8): 6663 - 6668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kametaka, M. Shibata, K. Moroe, S. Kanamori, Y. Ohsawa, S. Waguri, P. J. Sims, K. Emoto, M. Umeda, and Y. Uchiyama
Identification of Phospholipid Scramblase 1 as a Novel Interacting Molecule with beta -Secretase (beta -Site Amyloid Precursor Protein (APP) Cleaving Enzyme (BACE))
J. Biol. Chem., April 18, 2003; 278(17): 15239 - 15245.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-Y. Zhao, Y. Liu, R.-V. Stan, L. Fan, Y. Gu, N. Dalton, P.-H. Chu, K. Peterson, J. Ross Jr., and K. R. Chien
Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice
PNAS, August 20, 2002; 99(17): 11375 - 11380.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. V. Chochina, N. A. Avdulov, U. Igbavboa, J. P. Cleary, E. O. O'Hare, and W. G. Wood
Amyloid {beta}-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region
J. Lipid Res., August 1, 2001; 42(8): 1292 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. J. Smart, G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti
Caveolins, Liquid-Ordered Domains, and Signal Transduction
Mol. Cell. Biol., November 1, 1999; 19(11): 7289 - 7304.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-Y. Park, J.-S. Park, K.-A Cho, D.-I. Kim, Y.-G. Ko, J.-S. Seo, and S. C. Park
Up-regulation of Caveolin Attenuates Epidermal Growth Factor Signaling in Senescent Cells
J. Biol. Chem., June 30, 2000; 275(27): 20847 - 20852.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-